Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Pediatrics|January 4, 2007
Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf lifeStan L Block, Timo Vesikari, Michelle G Goveia, et al.
Vaccine|April 24, 2012
Comparison of two clinical severity scoring systems in two multi-center, developing country rotavirus vaccine trials in Africa and AsiaKristen D C Lewis, Michael J Dallas, John C Victor, et al.
Vaccine|April 24, 2012
Immunogenicity of the pentavalent rotavirus vaccine in African infantsGeorge E Armah, Robert F Breiman, Milagritos D Tapia, et al.
Vaccine|April 24, 2012
Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in KenyaDaniel R Feikin, Kayla F Laserson, Joel Ojwando, et al.
Vaccine|April 24, 2012
Immunogenicity of the pentavalent rotavirus vaccine among infants in two developing countries in Asia, Bangladesh and VietnamSunheang Shin, Dang Duc Anh, K Zaman, et al.
Vaccine|April 20, 2006
Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infantsTimo Vesikari, H Fred Clark, Paul A Offit, et al.
The Pediatric Infectious Disease Journal|March 6, 2015
Safety, tolerability and immunogenicity of 15-valent pneumococcal conjugate vaccine in toddlers previously vaccinated with 7-valent pneumococcal conjugate vaccineAjoke Sobanjo-ter Meulen, Timo Vesikari, Edgardo A Malacaman, et al.
The Journal of Pediatrics|February 5, 2004
Safety, efficacy, and immunogenicity of a live, quadrivalent human-bovine reassortant rotavirus vaccine in healthy infantsH Fred Clark, David I Bernstein, Penelope H Dennehy, et al.
Vaccine|April 24, 2012
Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan AfricaMilagritos D Tapia, George Armah, Robert F Breiman, et al.
The Pediatric Infectious Disease Journal|October 11, 2003
Safety, immunogenicity and efficacy in healthy infants of G1 and G2 human reassortant rotavirus vaccine in a new stabilizer/buffer liquid formulationH Fred Clark, Carl J Burke, David B Volkin, et al.
Pageof 3